BACKGROUND: Research shows that guidelines featuring implementation tools (GItools) are more likely to be used than those without GItools, however few guidelines offer GItools and guidance on developing GItools is lacking. The objective of this study was to identify common processes and considerations for developing GItools. METHODS: Interviews were conducted with developers of 4 types of GItools (implementation, patient engagement, point-of-care decision-making and evaluation) accompanying guidelines on various topics created in 2008 or later identified in the National Guideline Clearinghouse. Participants were asked to describe the GItool development process and related considerations. A descriptive qualitative approach was used to collect and analyze data. RESULTS: Interviews were conducted with 26 GItool developers in 9 countries. Participants largely agreed on 11 broad steps, each with several tasks and considerations. Response variations identified issues lacking uniform approaches that may require further research including timing of GItool development relative to guideline development; decisions about GItool type, format and content; and whether and how to engage stakeholders. Although developers possessed few dedicated resources, they relied on partnerships to develop, implement and evaluate GItools. INTERPRETATION: GItool developers employed fairly uniform and rigorous processes for developing GItools. By supporting GItool development, the GItool methods identified here may improve guideline implementation and use.
BACKGROUND: Research shows that guidelines featuring implementation tools (GItools) are more likely to be used than those without GItools, however few guidelines offer GItools and guidance on developing GItools is lacking. The objective of this study was to identify common processes and considerations for developing GItools. METHODS: Interviews were conducted with developers of 4 types of GItools (implementation, patient engagement, point-of-care decision-making and evaluation) accompanying guidelines on various topics created in 2008 or later identified in the National Guideline Clearinghouse. Participants were asked to describe the GItool development process and related considerations. A descriptive qualitative approach was used to collect and analyze data. RESULTS: Interviews were conducted with 26 GItool developers in 9 countries. Participants largely agreed on 11 broad steps, each with several tasks and considerations. Response variations identified issues lacking uniform approaches that may require further research including timing of GItool development relative to guideline development; decisions about GItool type, format and content; and whether and how to engage stakeholders. Although developers possessed few dedicated resources, they relied on partnerships to develop, implement and evaluate GItools. INTERPRETATION: GItool developers employed fairly uniform and rigorous processes for developing GItools. By supporting GItool development, the GItool methods identified here may improve guideline implementation and use.
Authors: William B Runciman; Tamara D Hunt; Natalie A Hannaford; Peter D Hibbert; Johanna I Westbrook; Enrico W Coiera; Richard O Day; Diane M Hindmarsh; Elizabeth A McGlynn; Jeffrey Braithwaite Journal: Med J Aust Date: 2012-07-16 Impact factor: 7.738
Authors: Anna R Gagliardi; Melissa C Brouwers; Valerie A Palda; Louise Lemieux-Charles; Jeremy M Grimshaw Journal: Implement Sci Date: 2011-03-22 Impact factor: 7.327
Authors: Patrick M Archambault; Tom H van de Belt; Craig Kuziemsky; Ariane Plaisance; Audrey Dupuis; Carrie A McGinn; Rebecca Francois; Marie-Pierre Gagnon; Alexis F Turgeon; Tanya Horsley; William Witteman; Julien Poitras; Jean Lapointe; Kevin Brand; Jean Lachaine; France Légaré Journal: Cochrane Database Syst Rev Date: 2017-05-10
Authors: Anna R Gagliardi; France Légaré; Melissa C Brouwers; Fiona Webster; Elizabeth Badley; Sharon Straus Journal: Implement Sci Date: 2016-02-29 Impact factor: 7.327
Authors: Ariane Plaisance; Holly O Witteman; Daren Keith Heyland; Mark H Ebell; Audrey Dupuis; Carole-Anne Lavoie-Bérard; France Légaré; Patrick Michel Archambault Journal: JMIR Res Protoc Date: 2016-02-11
Authors: Melissa J Armstrong; Gary S Gronseth; Richard Dubinsky; Sonja Potrebic; Rebecca Penfold Murray; Thomas S D Getchius; Carol Rheaume; Anna R Gagliardi Journal: BMC Med Inform Decis Mak Date: 2017-01-13 Impact factor: 2.796
Authors: Barbara Farrell; Kevin Pottie; Carlos H Rojas-Fernandez; Lise M Bjerre; Wade Thompson; Vivian Welch Journal: PLoS One Date: 2016-08-12 Impact factor: 3.240